Back to Search Start Over

Research progress of astragaloside IV in the treatment of atopic diseases.

Authors :
Yu, Shencun
Peng, Wendong
Qiu, Fanghong
Zhang, Guiju
Source :
Biomedicine & Pharmacotherapy. Dec2022, Vol. 156, pN.PAG-N.PAG. 1p.
Publication Year :
2022

Abstract

Atopic disease is a kind of abnormal immune reaction caused by tissue damage and physiological dysfunction caused by allergens. Atopic diseases involve many systems and have obvious genetic tendencies, threatening the quality of life, health, and life safety of human beings. Astragalus membranaceus is an ancient and commonly used traditional Chinese medicine widely used in allergic diseases. Astragaloside IV is one of the main active ingredients in Astragalus membranaceus and is an important index component for evaluating the quality of Astragalus membranaceus and Astragalus membranaceus preparations at present. It has good antiallergic and immunomodulatory effects. Therefore, this paper reviews and summarizes the mechanism of action, pharmacokinetics, and drug optimization research progress of astragaloside IV in the treatment of atopic diseases. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
07533322
Volume :
156
Database :
Academic Search Index
Journal :
Biomedicine & Pharmacotherapy
Publication Type :
Academic Journal
Accession number :
160212935
Full Text :
https://doi.org/10.1016/j.biopha.2022.113989